Through this partnership, the health care practitioner plays a key role in safely maximizing and monitoring the therapeutic outcomes for their patients
Prospective trial needed, but this result is pretty striking
GIPR antagonist effects in mice global loss of Gipr or Glp-1r We next assessed the ability of a mouse GIPR neutralizing antibody 23 (Kb of 5 nmol l 1 , potency for antagonism of GIP-induced cAMP accumulation) to affect HFD-induced weight gain and food intake in lean mice kept at thermoneutrality (28 C), an environmental temperature where potential confounding effects due to differences in metabolic rate are lowest
Protocol at a Glance: Dose: 250-500mcg daily Frequency: Once daily (can split to 2x if needed) Method: SubQ injection near injury or abdomen Duration: 4-8 weeks minimum Cost: $40-60 for 4-week cycle Results Timeline: Week 1-2: 30-50% pain reduction Week 3-4: 60-80% improvement in mobility Week 6-8: 80-95% healed (most users) Most users notice pain reduction within 1-2 weeks, with near-complete healing by week 6-8
Pettus on a phase 1/2 clinical trial that tested whether the addition of SGLTi to the glucagon receptor antagonist volagidemab can further improve glycemic control in people with T1D
Some researchers believe that GLP-1 may play a role in regulating emotions, but studies are still ongoing